Quoted Micro 27 April 2026
AQUIS STOCK EXCHANGE Silverwood Brands (SLWD) has published delayed results for the 18 months to June 2025. There were delays in consolidating the Japanese subsidiary accounts and the company intends to improve its financial reporting capability. Full year revenues were £23.9m and the reported loss was £18.3m. That was predominantly down to impairment charges. Cash […]
Quoted Micro 18 August 2025
AQUIS STOCK EXCHANGE Adsure Services (ADS) increased its final dividend by 15% to 1.14p/share. The business assurance provider increased full year pre-tax profit by 74% to £818,000 on revenues 8% higher at £10m. Other operating expenses were lower. Net cash was £1.1m at the end of March 2025. Investment in technology should help Adsure Services […]
Quoted Micro 21 April 2025
AQUIS STOCK EXCHANGE The Small Cap awards 2025 shortlist for Aquis company of the year comprises Ananda Pharma (ANA), EDX Medical (EDX), Oberon Investments (OBE), SulNOx Group (SNOX) and Valereum (VLRM). SulNOx Group has been granted patents for its fuel emissions reduction additives in eight African countries. Shares in Ananda Pharma have started trading on […]
Quoted Micro 23 September 2024
AQUIS STOCK EXCHANGE Digital assets investor KR1 (KR1) reported interim revenues from those digital assets improving from £3.91m to £8.72m, although lower gains on disposals of assets meant that the pre-tax profit edged up from £10m to £10.3m. There was £1.5m in cash in the balance sheet at the end of June 2024. NAV was […]
Quoted Micro 19 August 2024
AQUIS STOCK EXCHANGE ProBiotix Health (PBX) has secured a commercial agreement for InstaMelt with DanCare Health. InstaMelt is a food supplement dosage format that offers innovative features for health brands. DanCare will launch the supplement in China in the fourth quarter under its own brand. Samarkand (SMK) reported a dip in full year revenues from […]
Quoted Micro 10 June 2024
AQUIS STOCK EXCHANGE Skincare treatments developer Incanthera (INC) says the first production order for its Skin + CELL products from Marionnaud has been doubled to 100,000 units. The launch will be in September. The previous figure was already higher than the initial order and the revenues from the order will be £4m. Future production orders […]
Quoted Micro 12 February 2024
AQUIS STOCK EXCHANGE RentGuarantor (RCG) 2023 revenues were 3% ahead of Zeus forecasts and expects to upgrade its 2024 forecast in April after the accounts are released. The 2023 revenues were 73% higher at £742,000. There was a 57% increase in tenant contracts to 1,124. A new insurance partner has increased insurance cover for rent […]
Quoted Micro 18 December 2023
AQUIS STOCK EXCHANGE Flex Labs Inc (FLEX) joined the Access segment on 15 December. The Canada-registered company is developing AI middleware for natural language processing text generators. There is no product yet. The introduction price was 3p, which valued Flex Labs at £3.42m. The share price ended the week at 6p. Investment Evolution Credit (IEC) […]
Quoted Micro 3 April 2023
AQUIS STOCK EXCHANGE Aquis Stock Exchange owner Aquis Exchange (AQX) reported an increase in revenues from £17.2m to £19.9m in 2022. The pre-tax profit improved from £3.6m to £4.5m. that reflects the operational gearing. All three parts of the business were profitable. In the cash of the Aquis Stock Exchange this was probably the first […]
Quoted Micro 13 February 2023
AQUIS STOCK EXCHANGE Hemp and cannabinoid products supplier Yooma Wellness (YOOM) is restructuring its business due to the depressed market conditions. Unprofitable activities have been wound down and management is still trying to come up with a new strategy. The 2021 Vertex acquisition is being handed back to the sellers and $1.2m in receivables has […]